Viewing StudyNCT00024648



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00024648
Status: COMPLETED
Last Update Posted: 2011-04-13
First Post: 2001-09-24

Brief Title: Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies
Sponsor: INSYS Therapeutics Inc
Organization: INSYS Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Keywords:
Name View
LErafAON View
advanced malignancy View
liposomes containing AON to c-raf messenger RNA View
antisense oligodeoxynucleotide AON View